Schedule II Controlled Substances and Risks of Addiction

Course Overview

Course Outline

1. Introduction 
2. Recent History of Pain in the United States 
3. Pain 
4. Pain Theory 
5. Types of Pain by Origin 
6. Pain Classifications 
7. Assessing Pain 
8. 2022 CDC Guidelines for the Prescription of Opioids to Treat Chronic Pain 
9. Five Guiding Principles of the Guidelines 
10. Four Key Issues Addressed By the Guidelines 
11. Non-pharmacological Treatments for Pain 
12. Non-schedule II-Controlled Medications for Pain
13. Controlled Substance Act
14. Schedule I-V Controlled Substances 
15. How Opioids Work 
16. Dosing 
17. Assessing Effectiveness of Opioids 
18. Definitions Regarding Opioid Misuse 
19. Steps for Prescribing 
20. Patient Communication and Education 
21. Risk Factors for Opioid Misuse 
22. Diversion 
23. Opioid Use Disorder 
24. Tapering and Discontinuing Opioid Therapy

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Schedule II Controlled Substances and Risks of Addiction. It will take the average learner 180 minutes to complete and awards 3 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Discuss pharmacokinetic and pharmacodynamic principles of Schedule II medications.
2. Identify safe prescribing practices for opioid medications.
3. Describe signs of opioid misuse and use disorder

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.